Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas

被引:14
|
作者
Li, Jiali [1 ]
Liang, Lili [2 ]
Yu, Hao [1 ]
Shen, Yaqi [1 ]
Hu, Yao [1 ]
Hu, Daoyu [1 ]
Tang, Hao [1 ]
Li, Zhen [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongii Hosp, Dept Radiol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Nanyang Med Coll, Affiliated Hosp 1, Dept Radiol, Nanyang, Peoples R China
基金
中国国家自然科学基金;
关键词
Pancreatic carcinoma; Neuroendocrine tumors; Magnetic resonance imaging; Normal distribution; Microcirculation; INTRAVOXEL-INCOHERENT-MOTION; SURGICAL-MANAGEMENT; ADC MEASUREMENTS; GRADE; CARCINOMA; PERFUSION; VESSEL; VALUES;
D O I
10.1016/j.mri.2018.09.017
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the utility of volumetric histogram analysis of monoexponential and non-Gaussian distribution DWI models for discriminating pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine tumor (pNET). Materials and methods: A total of 340 patients were retrospectively reviewed. Finally, 62 patients with histopathological confirmed PDAC (n = 42) and pNET (n = 20) were enrolled in the study. All the patients accepted magnetic resonance imaging (MRI) at 3 T (including multi-b value DWI, 0-1000 s/mm(2)). Isotropic apparent diffusion coefficient (ADC), true molecular diffusion (Dt), perfusion-related diffusion (Dp), perfusion fraction (1), distributed diffusion coefficient (DDC) and alpha (a) were obtained from different DWI models. Then, mean value, median value, 10th and 90th percentiles were obtained from histogram analysis of each DWI parameter. Results: Histogram metrics derived from ADC, Dp, f and DDC were significantly lower in PDAC than pNET group (P < 0.05). In contrast, histogram metrics derived from a were observed significantly higher in the PDAC than pNET group (P < 0.05). No significant difference was found in Dt (P >= 0.05) between PDAC and pNET patients. Among all parameters, f-median had the highest diagnostic performance (AUC 0.91, cutoff value 0.188, sensitivity 97.62%, specificity 80%). Conclusions: f-Median derived from IVIM DWI model may be potentially more valuable parameter than ADC, Dp, DDC and a for discriminating PDAC and pNET. Histogram analysis based on the entire tumor was an emerging and valuable tool.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 50 条
  • [31] Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma
    Azoulay, A.
    Cros, J.
    Vullierme, M. -P.
    de Mestier, L.
    Couvelard, A.
    Hentic, O.
    Ruszniewski, P.
    Sauvanet, A.
    Vilgrain, V.
    Ronot, M.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2020, 101 (12) : 821 - 830
  • [32] Letter regarding “Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase”
    Shuai Ren
    Zhongqiu Wang
    Abdominal Radiology, 2021, 46 : 1648 - 1649
  • [33] Letter regarding "Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase"
    Ren, Shuai
    Wang, Zhongqiu
    ABDOMINAL RADIOLOGY, 2021, 46 (04) : 1648 - 1649
  • [34] Whole-Tumor Apparent Diffusion Coefficient (ADC) Histogram Analysis to Differentiate Benign Peripheral Neurogenic Tumors From Soft Tissue Sarcomas
    Nakajo, Masanori
    Fukukura, Yoshihiko
    Hakamada, Hiroto
    Yoneyama, Tomohide
    Kamimura, Kiyohisa
    Nagano, Satoshi
    Nakajo, Masayuki
    Yoshiura, Takashi
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 48 (03) : 680 - 686
  • [35] Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging
    Tianwen Xie
    Qiufeng Zhao
    Caixia Fu
    Qianming Bai
    Xiaoyan Zhou
    Lihua Li
    Robert Grimm
    Li Liu
    Yajia Gu
    Weijun Peng
    European Radiology, 2019, 29 : 2535 - 2544
  • [36] Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging
    Xie, Tianwen
    Zhao, Qiufeng
    Fu, Caixia
    Bai, Qianming
    Zhou, Xiaoyan
    Li, Lihua
    Grimm, Robert
    Liu, Li
    Gu, Yajia
    Peng, Weijun
    EUROPEAN RADIOLOGY, 2019, 29 (05) : 2535 - 2544
  • [37] Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase (vol 45, pg 750, 2020)
    Reinert, Christian Philipp
    Baumgartner, Karolin
    Hepp, Tobias
    Bitzer, Michael
    Horger, Marius
    ABDOMINAL RADIOLOGY, 2021, 46 (09) : 4523 - 4523
  • [38] Response to letter to the editor regarding the article "Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase"
    Reinert, Christian Philipp
    Horger, Marius
    ABDOMINAL RADIOLOGY, 2021, 46 (04) : 1650 - 1650
  • [39] Response to letter to the editor regarding the article “Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase”
    Christian Philipp Reinert
    Marius Horger
    Abdominal Radiology, 2021, 46 : 1650 - 1650
  • [40] Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the US neuroendocrine tumor study group
    Zhang, Xu-Feng
    Lopez-Aguiar, Alexandra G.
    Poultsides, George
    Makris, Eleftherios
    Rocha, Flavio
    Kanji, Zaheer
    Weber, Sharon
    Fields, Ryan
    Krasnick, Bradley A.
    Idrees, Kamran
    Smith, Paula M.
    Cho, Cliff
    Schmidt, Carl R.
    Maithel, Shishir K.
    Pawlik, Timothy M.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 231 - 240